ANDA 216072, held by Senores Pharms. Propranolol Hydrochloride.
As of Nov 15, 2026, ANDA 216072 (Propranolol Hydrochloride), held by Senores Pharms, was first approved by FDA on Oct 26, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 26, 2026 | Original application | Approved | None posted |
| Propranolol Hydrochloride10MG · tablet;oral | Propranolol Hydrochloride | Rx |
| Propranolol Hydrochloride20MG · tablet;oral | Propranolol Hydrochloride | Rx |
| Propranolol Hydrochloride40MG · tablet;oral | Propranolol Hydrochloride | Rx |
| Propranolol Hydrochloride60MG · tablet;oral | Propranolol Hydrochloride | Rx |
| Propranolol Hydrochloride80MG · tablet;oral | Propranolol Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
